 |
Zeev Estrov, M.D.
University of Texas MD Anderson Cancer Center |
CLL-STROMA INTERACTION
Role of STAT3 in CLL
Grant Awarded in 2008
Abstract:
CLL growth and survival is impacted by signals within the CLL cell. In the
bone marrow, certain signals cause the CLL cells to undergo "spontaneous"
death. Recently, we identified an intracellular signaling protein, STAT-3, that
stimulates CLL cell growth and survival. (STAT-3 has a similar activation effect
in other leukemias).
Specific inhibitors of STAT-3 suppress CLL cell proliferation and kill CLL
cells. Interleukin-6, a cytokine or regulatory protein derived from bone marrow
cells, appears to counteract the inhibitor effect thereby keeping the CLL cells
alive. Therefore, we asked whether external signals such as cytokines would hamper
the effects of STAT-3 inhibitors.
To answer this question, we will conduct experiments with CLL bone marrow cells,
normal cells and outside growth factors. We will explore how bone marrow-supportive
cells "fight" CLL cells. Our hypothesis is that bone marrow supportive
cells recognize an expanding population of CLL cells and generate factors to stop
cell growth. While cytokines may be capable of killing CLL cells, they might also
suppress normal cells thereby inducing low blood count in patients with CLL.
We will investigate how the bone marrow responds to a growing clone of CLL
cells, and whether CLL marrow supports and stimulates the development of precursor
cells. Understanding the roles of these factors in maintaining CLL cells will
allow us to development future CLL treatments.
|